Embolic Protection Device
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
20
NCT04659538
The CAPTIS® Study - Embolic Protection in TAVR
Phase: N/A
Role: Lead Sponsor
Start: Nov 24, 2020
Completion: May 3, 2022
Loading map...